ArticleFrontiers in oncology2025

Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients.

Tara Seery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.